Johnson and Johnson: A Global Approach to Healthcare
Running head: JOHNSON & JOHNSON – FROM BAND-AIDS TO SAVING LIVES
Johnson & Johnson: A Global Approach to Health Care
Your Name Here
Webster University Abstract
Johnson & Johnson is a world leader in health care products and services. In this paper, I thoroughly analyze the foundation of Johnson & Johnson to determine the characteristics that make the corporation successful. My paper explains the organizational structure within the company and identifies a few members on the board of directors. I will show you that a firm allegiance to the Credo throughout global operations helps foster successful corporate social responsibility. The grand strategy that Johnson & Johnson employs is concentrated growth in the health care sector. The paper also features two internal analyses: a resource based analysis and a SWOT analysis. The conclusion of this paper is a discussion on benchmarking and illustrates some of the reasons Johnson & Johnson will be a dominant and powerful company for years to come. Johnson & Johnson: A Global Approach to Health Care Johnson & Johnson is a company entrenched in health care products and services that improve human well being. Since its formation in 1887, Johnson & Johnson expanded into a global corporation that controls over 230 companies worldwide. Look no further than your shower, medicine cabinet, or glove compartment to find a Johnson & Johnson product. This paper will show you that the company is (a) lead by experts, (b) committed to social responsibility, and (c) determined to control the market share of the health care industry. I will show you through careful analysis and examples of excellence that Johnson & Johnson is a solid company, worthy of your investment.
The Credo In lieu of a mission statement, vision statement, or a statement of values, the former Chairman of the Board, General Robert Wood Johnson, created a one page document to outline the operating principles that guide the company. Written and
Johnson & Johnson: A Global Approach to Health Care
Your Name Here
Webster University Abstract
Johnson & Johnson is a world leader in health care products and services. In this paper, I thoroughly analyze the foundation of Johnson & Johnson to determine the characteristics that make the corporation successful. My paper explains the organizational structure within the company and identifies a few members on the board of directors. I will show you that a firm allegiance to the Credo throughout global operations helps foster successful corporate social responsibility. The grand strategy that Johnson & Johnson employs is concentrated growth in the health care sector. The paper also features two internal analyses: a resource based analysis and a SWOT analysis. The conclusion of this paper is a discussion on benchmarking and illustrates some of the reasons Johnson & Johnson will be a dominant and powerful company for years to come. Johnson & Johnson: A Global Approach to Health Care Johnson & Johnson is a company entrenched in health care products and services that improve human well being. Since its formation in 1887, Johnson & Johnson expanded into a global corporation that controls over 230 companies worldwide. Look no further than your shower, medicine cabinet, or glove compartment to find a Johnson & Johnson product. This paper will show you that the company is (a) lead by experts, (b) committed to social responsibility, and (c) determined to control the market share of the health care industry. I will show you through careful analysis and examples of excellence that Johnson & Johnson is a solid company, worthy of your investment.
The Credo In lieu of a mission statement, vision statement, or a statement of values, the former Chairman of the Board, General Robert Wood Johnson, created a one page document to outline the operating principles that guide the company. Written and
References: Abelson, R. (2004, February 25). Johnson takes ally to try and keep lead in stents. New York Times, pp. C1-C7. Annual Report. (2005). Johnson & Johnson 2005 Annual Report. Available from http://www.jnj.com/investor/documents/archive/jnj_2005annual.pdf. Anonymous Hensley, S. (2006, May 17). Side effect concerns grow for drugs to treat rheumatoid arthritis. Wall Street Journal, pp. D1-D4. Johnson & Johnson Website. (2007). Available from http://www.jnj.com. Park, K. (2007). Johnson & Johnson. Retrieved February 18, 2007 from http://www.hoovers.com/johnson-&-johnson/--ID__10824--/free-co-factsheet.xhtml. Pearce, J.A., & Robinson, R.B. (2007). Strategic Management: Formulation Implementation, and Control. (10th ed.) New York: McGraw Hill/Irwin. Thomaselli, R. (2005). J&J stance on DTC ads irks rivals. Advertising Age, (76)13, p.2. Retrieved February 10, 2007, from http://web.ebscohost.com.library3.webster.edu/ehost/detail?vid=25&hid=12&sid=e6e1cfa8-14f3-4fcf-b099-dbdacd7e4dfb%40sessionmgr3. Torlee, L. (2005). A swift kick in the credo. Marketing Magazine, (110)11, p. 25. Retrieved January 27, 2007, from http://web.ebscohost.com.library3.webster.edu/ehost/detail?vid=24&hid=103&sid=66ec35b2-45ad-44b7-8ccd-74549139943f%40sessionmgr8.